BTAI $8.24 -0.59 (-6.68%)
Wed, Feb 20, 2019
BioXcel Therapeutics Inc is a Health Care stock that trades on the NASDAQ with a market cap of $140 Million
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, which is a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company's other product candidates are BXCL502 and BXCL702 which is focused on neurodegeneration and hematological malignancies. http://www.bioxceltherapeutics.com
BioXcel Therapeutics Inc Stock Charts
BTAI Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $8.24.
The Year To Date (YTD) return is +136.10%.
52 Week Low
The 52 Week Low stock price is $2.41 set on Wed, Dec 26, 2018 which is 57 days ago.
The current price per share is 241.91% above the 52 week low.
52 Week High
The 52 Week High stock price is $12.99 set on Tue, Jul 10, 2018 which is 226 days ago.
The current price per share is -36.57% below the 52 week high.
All Time High
The All Time High stock price is $12.99 set on Tue, Jul 10, 2018 which is 226 days ago.
The current price per share is -36.57% below the all time high.
BTAI Stock Split History
BioXcel Therapeutics Inc has had 0 stock splits.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.31 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for BioXcel Therapeutics Inc was Wed, Aug 8, 2018.
Since this earnings release 197 days ago, the stock price is down by -19.06%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Fri, Nov 9, 2018, which was 104 days ago.
Since this earnings date, the stock price is up by +36.20%.
BioXcel Therapeutics Inc Dividend
Below is important Dividend information.
BTAI currently does not pay a dividend.
You may like this list of best dividend stocks of 2019.
Below are some other Biotech & Pharma industry stocks like BioXcel Therapeutics Inc.